Hatteras Venture Partners key facts
- Hatteras Venture Partners is a venture capital firm based in Durham, North Carolina with 37 tracked portfolio companies.
- Notable positions include Caidya, Ten63 Therapeutics, Tune Therapeutics.
- The team roster lists 2 people.
About Hatteras Venture Partners
Founded in 2000, Hatteras Venture Partners is a venture capital firm based in Durham, North Carolina. The firm prefers to invest in commercial services, healthcare devices and supplies, healthcare technology systems, pharmaceuticals and biotechnology, software, SaaS, life sciences, and oncology sectors operating in the United States. This firm is a Registered Investment Adviser (RIA).
Hatteras Venture Partners portfolio at a glance
37 portfolio companies are on record for Hatteras Venture Partners, including Caidya, Ten63 Therapeutics and Tune Therapeutics.
29 of the 37 carry a recorded valuation.
Hatteras Venture Partners team
2 people are on record at Hatteras Venture Partners: 1 partner and 1 general partner. Senior names include Douglas Reed (General Partner) and Myla Lai-Goldman (Venture Partner). 2 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 37 recorded positions
- ·Watchlist + alerts for Hatteras Venture Partners's activity
Portfolio
37 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Caidya | Other Healthcare Services | ▮ | ▮ | ▮ |
| Ten63 Therapeutics | — | ▮ | ▮ | ▮ |
| Tune Therapeutics | — | ▮ | ▮ | ▮ |
+ 34 more companies · all 37, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Hatteras Venture Partners
- What companies does Hatteras Venture Partners invest in?
- Hatteras Venture Partners has 37 recorded portfolio companies, including Caidya, Ten63 Therapeutics, Tune Therapeutics.
- What is Hatteras Venture Partners's AUM?
- Hatteras Venture Partners manages approximately $900.0M in assets.